Two of the three routes to a cosmetic claim cost more than they should. A 3-minute read on AICIS, ACCC, and how to land on the route that compounds.
Gut health, longevity, neurowellness — three of the biggest wellness categories in 2026 all share the same problem: marketing language that has outrun the evidence. Here’s what evidence-first strategy looks like in practice.
The global creatine market hit $1.1B in 2024 — driven by brain health and women’s wellness, not just gym performance. We explore what this tells health brands about evidence timing and building defensible claims before the trend peaks.
“Longevity” commands a price premium but has no regulatory definition. We break down the FTC, TGA, and NZ claim landscape — and what brands in the anti-aging space need to know before going to market.
There’s no regulatory definition of “clean” in cosmetics — and brands are paying for it in court. We break down the litigation wave, the ANZ regulatory picture, and what defensible natural claims look like.
